Related Experiment Video
Updated: Sep 12, 2025
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
Biosimilars and interchangeability: Regulatory, scientific, and global perspectives
1Department of Medical Pharmacology, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
Summary
Biosimilars offer increased access to biological medicines by demonstrating high similarity to reference products without clinically meaningful differences. Rigorous scientific evaluation ensures their safety and efficacy are comparable to original biologics.
Area of Science:
- Biopharmaceutical science
- Regulatory science
- Clinical pharmacology
Background:
- Biological medicines (biologics) have revolutionized treatment but are expensive.
- Biosimilars provide a more accessible alternative as original biologic patents expire.
Purpose of the Study:
- To review the scientific foundation of biosimilars.
- To examine the concept of interchangeability and global regulatory frameworks.
- To discuss evidence supporting biosimilar safety and efficacy.
Main Methods:
- Review of scientific principles for biosimilar development.
- Analysis of regulatory requirements (EMA, FDA, WHO) for comparability.
- Evaluation of analytical, pharmacokinetic/pharmacodynamic, and immunogenicity data.
- Assessment of interchangeability criteria, including switching studies and real-world evidence.
Main Results:
- Biosimilars are developed through rigorous comparability processes to match reference product attributes.
- Global regulatory agencies have established frameworks for biosimilar approval.
- Evidence supports the safety and efficacy of biosimilar substitution and interchangeability.
Conclusions:
- Biosimilars are highly similar to reference biologics with no clinically meaningful differences.
- Regulatory science ensures biosimilar safety, purity, and efficacy.
- Biosimilars enhance patient access to critical biologic therapies.
More Related Videos
Related Concept Videos
01:16Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
246
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
246
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:28Global Regulatory Systems
73
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
73